IE
IDYA icon

Israel Englander’s IDEAYA Biosciences IDYA Stock Holding History

Israel Englander’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-126,800
Closed -$4.22M – 6100
2026
Q1 		$4.22M Buy
+126,800
New +$4.25M ﹤0.01% 3144
2021
Q2 		– Sell
-18,200
Closed -$428K – 6755
2021
Q1 		$428K Buy
+18,200
New +$351K ﹤0.01% 4945

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Israel Englander's IDYA Position: Q2 2026 in Review

Israel Englander reduced its IDEAYA Biosciences (IDYA) stake by 95% in Q2 2026, selling an estimated $6.69M and leaving 10,500 shares worth $391K. The position accounts for ﹤0.01% of the portfolio, ranked #4949.

Israel Englander first reported a position in IDYA in Q2 2019 and has held it in 25 quarters since. The position peaked at $10.8M in Q3 2024. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Israel Englander held 10,500 shares of IDEAYA Biosciences worth $391K as of Q2 2026.
  • Israel Englander sold 218,480 IDEAYA Biosciences shares in Q2 2026, an estimated $6.69M.
  • IDEAYA Biosciences made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4949 holding.
  • Israel Englander first reported a position in IDEAYA Biosciences in Q2 2019 and has held it in 25 quarters since.
  • Israel Englander's IDEAYA Biosciences position peaked at $10.8M in Q3 2024.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.